What's new about the new oral diabetes drugs

Patient Care

Volumn 30, Issue 12, 1996, Pages 40-66

  Cefalu, William ^a,b,c   Colwell, John ^d   King, George L ^e,f  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b North Carolina Baptist Hospital   (United States)

^c AMERICAN DIABETES ASSOCIATION   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2642630527     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized, prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117.
3. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 1994;17:616-623.
4. Bailey CJ, Turner RC: Metformin. N Engl J Med 1996;334:574-579.
5. Abraira C, Colwell JA, Nuttall FQ, et al: Veterans Affairs Cooperative Study on Glycemic Control and Complications in type II diabetes (VA CSDM): Results of the feasibility trial: Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 1995;18:1113-1123.
6. Johnson JL, Wolf SL, Kabadi UM: Efficacy of insulin and sulfonylurea combination therapy in type II diabetes: A meta-analysis of the randomized placebo-controlled trials. Arch Intern Med 1996;156:259-264.